Similarly, in acute myeloid leukemia (AML) and ovarian cancer, the overexpression of fatty acid-β-oxidation-related enzymes, such as CPT1A, has been associated with poor patient prognosis (62). The gene discussed is CPT1A; the disease is acute myeloid leukemia.